Business, energy, technology, markets and global industry news from Business News Today

infectious disease vaccines

PharmaDeviceNews infectious disease vaccines
Representative image of next-generation vaccine research, showing how AAHI’s SLA-SE adjuvant technology is gaining attention through Eli Lilly and Company’s acquisition of Curevo Vaccine and its shingles vaccine candidate amezosvatein.
Pharma & Biotech

Lilly’s Curevo deal turns AAHI’s adjuvant science into a late-stage vaccine opportunity

Find out how AAHI’s SLA-SE adjuvant could shape Lilly’s next-generation shingles vaccine strategy after the Curevo acquisition.

Read More
Pharma & Biotech

Can Evaxion A/S’s AI-designed polio vaccine concepts reshape the final mile of eradication?

Evaxion A/S unveils AI-designed polio vaccine concepts with eradication potential. Read what this means for vaccine innovation and platform risk.

Read More